<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1409-1429</journal-id>
<journal-title><![CDATA[Revista Costarricense de Salud Pública]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. costarric. salud pública]]></abbrev-journal-title>
<issn>1409-1429</issn>
<publisher>
<publisher-name><![CDATA[Asociación Costarricense de Salud Pública]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1409-14292019000100036</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Aplicación del índice pronóstico de supervivencia Pap score en el paciente oncológico referido al Centro Nacional de Control del Dolor y Cuidados Paliativos en Costa Rica]]></article-title>
<article-title xml:lang="en"><![CDATA[Application of the survival prognosis index (Pap score) in the oncological patient referred to the National Center for Pain Control and Palliative Care in Costa Rica]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alfaro-Campos]]></surname>
<given-names><![CDATA[Grethel Carolina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vargas-Bermúdez]]></surname>
<given-names><![CDATA[Alejandro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Centro Nacional de Control del Dolor y Cuidados Paliativos Servicio de Medicina Paliativa ]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro Nacional de Control del Dolor y Cuidados Paliativos Servicio de Medicina Paliativa ]]></institution>
<addr-line><![CDATA[ San José]]></addr-line>
<country>Costa Rica</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>36</fpage>
<lpage>47</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_arttext&amp;pid=S1409-14292019000100036&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_abstract&amp;pid=S1409-14292019000100036&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.sa.cr/scielo.php?script=sci_pdf&amp;pid=S1409-14292019000100036&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo:  Determinar la validez del Índice de Pronóstico de Supervivencia (PapScore) en los pacientes oncológicos referidos al Centro Nacional de Control del Dolor y Cuidados Paliativos de Costa Rica.  Métodos:  Estudio descriptivo, observacional y prospectivo de los pacientes oncológicos referidos por primera vez al Centro Nacional de Control del Dolor y Cuidados Paliativos durante los meses de mayo y junio del 2015. Se aplicó el índice de pronóstico PaP Score. La base de datos fue realizada en Excel y el análisis estadístico en el programa SPSS.  Resultados:  Se estudiaron 100 pacientes, el 54% de sexo masculino, con una edad promedio 67,1 años. El cáncer gástrico fue la patología más prevalente con 12% de los casos. El 23% de pacientes presentan disnea, 56% anorexia. A la mayoría de pacientes (67%) se le realizó una estimación clínica mayor a 12 semanas. Un 83% fueron clasificados en el grupo A, 17% en el grupo B y ningún paciente en el grupo C. Analizando la clasificación de riesgo como un test diagnóstico para predecir mortalidad a un mes, muestra un sensibilidad del 61,9%, especificidad del 94,9%, con valor predictivo positivo 76,5% y valor predictivo negativo 90,4%.  Conclusión:  La escala de PaP Score o Índice Pronóstico de Supervivencia es un instrumento que se adapta a las posibilidades de nuestro entorno nacional. Es una excelente herramienta como predictor de sobrevida a un mes, independientemente del tipo de tumor, con alta eficacia y validez pronóstica.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective:  To determine the validity of the Palliative Prognosis Index (PapScore) in cancer patients referred to the National Center for Pain Control and Palliative Care of Costa Rica.  Methods:  Descriptive, observational and prospective study of oncological patients referred for the first time to the National Center of Pain Control and Palliative Care during the months of May and June 2015. The PaP Score was used. The database was made in Excel and the statistical analysis in the SPSS program.  Results:  100 patients were studied, 54% male, with an average age of 67.1 years. Gastric cancer was the most prevalent pathology with 12% of cases, 23% of patients present dyspnea, 56% anorexia. The majority of patients (67%) underwent a clinical prognosis of more than 12 weeks, 83% were classified in group A, 17% in group B and no patient in group C. Analyzing the risk classification as a diagnostic test to predict mortality at one month, shows a sensitivity of 61.9%, specificity 94.9%, with positive predictive value 76.5% and negative predictive value 90.4%.  Conclusion:  The PaP Score or Palliative Prognosis Index scale is an instrument that adapts to the possibilities of our national environment. It is an excellent tool as a predictor of survival at one month, regardless of the type of tumor, with high efficacy and prognostic validity.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Cuidados Paliativos]]></kwd>
<kwd lng="es"><![CDATA[Neoplasias]]></kwd>
<kwd lng="es"><![CDATA[Supervivencia]]></kwd>
<kwd lng="es"><![CDATA[Costa Rica.]]></kwd>
<kwd lng="en"><![CDATA[Palliative Care]]></kwd>
<kwd lng="en"><![CDATA[Neoplasms]]></kwd>
<kwd lng="en"><![CDATA[Survival]]></kwd>
<kwd lng="en"><![CDATA[Costa Rica]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Myers]]></surname>
<given-names><![CDATA[Jeff]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Palliative performance scale and survival among outpatients with advanced cancer]]></article-title>
<source><![CDATA[Support Care Cancer]]></source>
<year>2015</year>
<volume>23</volume>
<page-range>913-8</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oludamidola]]></surname>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the Palliative Performance Scale in the Acute Tertiary Care Hospital Setting]]></article-title>
<source><![CDATA[Journal of Palliative Medicine]]></source>
<year>2007</year>
<volume>10</volume>
<page-range>1</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Díaz Nova]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego Machado]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[El Pronóstico]]></article-title>
<source><![CDATA[Rev Cubana Gen Integr]]></source>
<year>2004</year>
<volume>20</volume>
<page-range>2</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Nogales]]></surname>
<given-names><![CDATA[Benjamín Luis]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validación del Índice Pronóstico de Supervivencia (PaP Socre) en Cuidados Paliativos]]></article-title>
<source><![CDATA[Gaceta Mexicana de Oncología]]></source>
<year>2014</year>
<volume>13</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>162-6</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Francis]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Use of the Palliative Performance Scale (PPS) for End-of-Life prognostication in a palliative Medicine Consultation Service]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>2009</year>
<volume>37</volume>
<page-range>965-72</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tatsuya]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validity of the Palliative Performance Scale from a Survival Perpective]]></article-title>
<source><![CDATA[J Palliative Care]]></source>
<year>1999</year>
<volume>18</volume>
<page-range>2-3</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pirovano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new Palliative prognostic score (PaP Score) a first step for staging terminally ill cancer patients]]></article-title>
<source><![CDATA[J Pain Symptom Manage]]></source>
<year>1999</year>
<volume>17</volume>
<page-range>231-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pirovano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scarpi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of survavial of patients terminally ill with cancer. Results of an Italian prospective multicenter study]]></article-title>
<source><![CDATA[Cancer]]></source>
<year>1995</year>
<volume>75</volume>
<page-range>2613-22</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Biological indices predictive of survival in 519 Italian terminally ill cancer patients]]></article-title>
<source><![CDATA[J Pain Symptom Manage]]></source>
<year>1997</year>
<volume>13</volume>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Successful validation of the palliative prognostic score in terminally ill cancer patients]]></article-title>
<source><![CDATA[J Pain Symptom Manage]]></source>
<year>1999</year>
<volume>17</volume>
<page-range>240-7</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Parkes]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Accuracy of predictions of survival in later stages of cancer]]></article-title>
<source><![CDATA[Br Med J]]></source>
<year>1997</year>
<volume>2</volume>
<page-range>29-31</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Foster]]></surname>
<given-names><![CDATA[LE]]></given-names>
</name>
<name>
<surname><![CDATA[Lynn]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Predicting life span for applicants to inpatients hospice]]></article-title>
<source><![CDATA[Arch intern Med]]></source>
<year>1988</year>
<volume>148</volume>
<page-range>2540-3</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hardy]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
<name>
<surname><![CDATA[Turner]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Saunders]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of survival in an hospital-based continuing care unit.]]></article-title>
<source><![CDATA[Eur J Cancer]]></source>
<year>1994</year>
<volume>30A</volume>
<page-range>284-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Caraceni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Brunelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors in advanced cancer patients: Evidence-Based clinical recommendations.]]></article-title>
<source><![CDATA[Journal of Clinical Oncology]]></source>
<year>2005</year>
<volume>23</volume>
<numero>25</numero>
<issue>25</issue>
<page-range>6240-8</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Christakis]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Escarse]]></surname>
<given-names><![CDATA[JJ.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survival of Medicare patiens after enrollment in hospice programs.]]></article-title>
<source><![CDATA[New Engl J Med]]></source>
<year>1996</year>
<volume>335</volume>
<page-range>172-8</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Christakis]]></surname>
<given-names><![CDATA[NA]]></given-names>
</name>
<name>
<surname><![CDATA[Lamont]]></surname>
<given-names><![CDATA[EB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Extent and determinants of error in doctors' prognoses in terminally ill patients prospective cohort study]]></article-title>
<source><![CDATA[Br Med J]]></source>
<year>2000</year>
<volume>320</volume>
<page-range>469-73</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Why do doctors overestimate?]]></article-title>
<source><![CDATA[British Medicine Journal]]></source>
<year>2000</year>
<volume>320</volume>
<page-range>472</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognoses should be based on proved indices not intuition]]></article-title>
<source><![CDATA[British Medicine Journal]]></source>
<year>2000</year>
<volume>320</volume>
<page-range>473</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gonzalez]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Tratado de Medicina Paliativa y tratamiento de soporte del paciente con cancer]]></source>
<year>2007</year>
<page-range>793</page-range><publisher-name><![CDATA[Editorial Panamericana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Arriba Mendez]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pronóstico de supervivencia en el cancer avanzado]]></article-title>
<source><![CDATA[Rev Clin Espa]]></source>
<year>2007</year>
<volume>207</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>348-51</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Nanni]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Derni]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinica prediction of Survival is More Accurate than the Karnosky Performances Status in estimating Life Span of Terminally ill Cancer Patients.]]></article-title>
<source><![CDATA[Eur J Cancer]]></source>
<year>1994</year>
<volume>30A</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>764-6</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Caraceni]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Brunelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors in advanced cancer patients evidence-based clinical recommendations. A study by the Steering Committee of the European Association for Palliative Care]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Broeckaert]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Oncol]]></source>
<year>2005</year>
<volume>23</volume>
<page-range>6240-8</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stevinson]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Preston]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Todd]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer Experiences Collaborative (CECo) Defining priorities in prognostication research: results of a consensus workshop]]></article-title>
<source><![CDATA[Palliati Med]]></source>
<year>2010</year>
<volume>24</volume>
<page-range>462-8</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Scarpi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Pittureri]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prospective Comparison of Prognostic Score in Palliative Care Cancer Populations]]></article-title>
<source><![CDATA[The Oncologist]]></source>
<year>2012</year>
<volume>17</volume>
<page-range>446-54</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morita]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Tsunoda]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Palliative Prognostic Index a scoring system for survival prediction of terminally ill cancer patients]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Inoue]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Support Care Center]]></source>
<year>1996</year>
<volume>12</volume>
<page-range>5-11</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Scarpi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Maltoni]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Micell]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Survival Prediction for Terminally Ill Cancer Patients Revision of the Palliative Prognostic Score with Incorporation of Delirium]]></article-title>
<source><![CDATA[The Oncologist]]></source>
<year>2011</year>
<volume>16</volume>
<page-range>1793-9</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Inouye]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
<name>
<surname><![CDATA[Van Dick]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Alessi]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clarifying confusion The confusion assessment method. A new method for detection of delirium]]></article-title>
<source><![CDATA[Ann Intern Med]]></source>
<year>1990</year>
<volume>113</volume>
<page-range>941-8</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="">
<collab>INEC</collab>
<article-title xml:lang=""><![CDATA[Envejecimiento poblacional y desarrollo.]]></article-title>
<source><![CDATA[I Informe estado de situación de la persona adulta mayor en Costa Rica]]></source>
<year>2012</year>
</nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Glare]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Independent prospective validation of the PaP Score in terminally ill patients refered to a hospital based palliative medicina consultation service.]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management]]></source>
<year>2001</year>
<volume>22</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>891-8</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="">
<collab>Ministerio de Salud</collab>
<source><![CDATA[]]></source>
<year></year>
<publisher-loc><![CDATA[Costa Rica ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="book">
<collab>Unidad de Estadística-Registro Nacional de Tumores.</collab>
<source><![CDATA[Incidencia y Mortalidad del Cáncer en Costa Rica 1990-2003.]]></source>
<year></year>
<publisher-name><![CDATA[Ministerio de Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Medina]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Fundamentos de Oncología]]></source>
<year>2012</year>
<page-range>77</page-range><publisher-name><![CDATA[McGraw Hill]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dudgeon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kristjanson]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dyspnea in Cancer Patients: Prevalence and Associated Factors.]]></article-title>
<source><![CDATA[Journal of Pain and Sympton Management,]]></source>
<year>2001</year>
<volume>21</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>95-102</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Currow]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Davidson]]></surname>
<given-names><![CDATA[P.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Do the trajectories of dispnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study.]]></article-title>
<source><![CDATA[Journal of Pain and Symptom Management,]]></source>
<year>2010</year>
<volume>39</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>680-90</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Casa Fernández]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Guía Anorexia Caquexia]]></source>
<year>2005</year>
<volume>179</volume>
<publisher-name><![CDATA[Sociedad Española de Oncología Médica (SEOM)]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moreno Nogueira]]></surname>
<given-names><![CDATA[J.A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prevalencia de la malnutrición en pacientes con cáncer: estudio NUPAC. 2004.]]></article-title>
<source><![CDATA[Nutrición Clínica y dietética hospitalaria]]></source>
<year></year>
<volume>24</volume>
<page-range>17-8</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karnofky]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Albelman]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
<name>
<surname><![CDATA[Craver]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Burchenal]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of nitrogen mustards in the palliative treatment of carcinoma]]></article-title>
<source><![CDATA[Cáncer]]></source>
<year>1948</year>
<numero>1</numero>
<issue>1</issue>
<page-range>634-56</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karnofsky]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
<name>
<surname><![CDATA[Burchenal]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<source><![CDATA[The clinical evaluation of chemotherapeutic agents in cancer. En: Evaluation of chemotherapeutic agents]]></source>
<year>1949</year>
<publisher-loc><![CDATA[New York, ]]></publisher-loc>
<publisher-name><![CDATA[CM MacLeod]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pastrana]]></surname>
<given-names><![CDATA[T.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Palliative care development in Latin America: An analisis using macro indicators.]]></article-title>
<source><![CDATA[Palliative Medicine]]></source>
<year>2014</year>
<volume>29</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1231-8</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
